普莱克塔辛是一种具有治疗潜力的类抗生素,来自一种沙性真菌
Per H Mygind1, Rikke L Fischer, Kirk M Schnorr
1Novozymes A/S, 2880 Bagsvaerd, Denmark.
Nature
|October 14, 2005
概括
会产生一种新型的抗微生物,即斑素,它对抗药物耐药细菌有效. 这种防御蛋白显示出具有低毒性的治疗潜力,提供了一种新的抗生素来源.
科学领域:
- 生物化学 生物化学
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 动物和植物产生防御素,它们是对微生物活跃的类抗生素.
- 这些防御蛋白是小的,富含氨酸的,具有抗菌性质.
研究的目的:
- 为了识别和表征来自真菌的新型防御蛋白.
- 为了评估一种真菌防御素的抗菌活性和治疗潜力,plectasin.
主要方法:
- 从真菌Pseudoplectania nigrella中分离和结构分析斑素.
- 生产复合斑质素.复合斑质素的生产.
- 在体外抗微生物测定对肺炎链球菌,包括耐药菌株.
- 在小鼠体内有效性和毒性研究.
主要成果:
- 素,第一个真菌防御蛋白,与其他物种的防御蛋白具有结构上的相似性.
- 再组合斑素是以高产量和纯度生产的.
- 普莱克塔辛对Streptococcus pneumoniae表现出强烈的活性,包括抗生素耐药菌株.
- 普莱克塔辛在小鼠中表现出低毒性,并有效治疗S. pneumoniae引起的腹膜炎和肺炎.
结论:
- 菌代表了抗菌防御素的新来源.
- 充血素作为一种新型抗生素具有显著的治疗潜力.
- 这些发现表明,各种物种的防御蛋白具有共同的进化起源.
相关概念视频
Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Gene Regulation in Microbial Communities: Quorum Sensing
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


